pDONR223-CAMK2A Citations (4)

Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal

---

Articles Citing pDONR223-CAMK2A

Articles
The Ras-like GTPase Rem2 is a potent inhibitor of calcium/calmodulin-dependent kinase II activity. Royer L, Herzog JJ, Kenny K, Tzvetkova B, Cochrane JC, Marr MT 2nd, Paradis S. J Biol Chem. 2018 Sep 21;293(38):14798-14811. doi: 10.1074/jbc.RA118.003560. Epub 2018 Aug 2. PubMed
Suppression of CaMKIIbeta Inhibits ANO1-Mediated Glioblastoma Progression. Sim KM, Lee YS, Kim HJ, Cho CH, Yi GS, Park MJ, Hwang EM, Park JY. Cells. 2020 Apr 26;9(5). pii: cells9051079. doi: 10.3390/cells9051079. PubMed
RBL1/p107 Expression Levels Are Modulated by Multiple Signaling Pathways. Ventura E, Iannuzzi CA, Pentimalli F, Giordano A, Morrione A. Cancers (Basel). 2021 Oct 8;13(19). pii: cancers13195025. doi: 10.3390/cancers13195025. PubMed
Controlling the interaction between CaMKII and Calmodulin with a photocrosslinking unnatural amino acid. Lucic I, Jiang PL, Franz A, Bursztyn Y, Liu F, Plested AJR. Protein Sci. 2023 Nov;32(11):e4798. doi: 10.1002/pro.4798. PubMed

If you have published an article using this material, please email us at to have your article added to this page.